Previous Article | Next Article 
Journal of Virology, August 2000, p. 7411-7421, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Construction and Characterization of Murine
Cytomegaloviruses That Contain Transposon Insertions at Open Reading
Frames m09 and M83
Xiaoyan
Zhan,
Manfred
Lee,
Jianqiao
Xiao, and
Fenyong
Liu*
Program in Infectious Diseases and Immunity,
School of Public Health, University of California, Berkeley,
California 94720
Received 6 March 2000/Accepted 3 May 2000
 |
ABSTRACT |
A transposon derived from Escherichia coli
Tn3 was introduced into the genome of murine
cytomegalovirus (MCMV) to generate a pool of viral mutants, including
two recombinant viruses that contained the transposon sequence within
open reading frames m09 and M83. Our studies provide the first direct
evidence to suggest that m09 is not essential for viral replication in
mouse NIH 3T3 cells. Studies in cultured cells and in both BALB/c-Byj
and CB17 severe combined immunodeficient (SCID) mice indicated that the transposon insertion is stable during viral propagation both in vitro
and in vivo. Moreover, the virus that contained the insertion mutation
in m09 exhibited a titer similar to that of the wild-type virus in the
salivary glands, lungs, livers, spleens, and kidneys of both the BALB/c
and SCID mice and was as virulent as the wild-type virus in killing the
SCID mice when these animals were intraperitoneally infected with these
viruses. These results suggest that m09 is dispensable for viral growth
in these organs and that the presence of the transposon sequence in the
viral genome does not significantly affect viral replication in vivo.
In contrast, the virus that contained the insertion mutation in M83
exhibited a titer of at least 60-fold lower than that of the wild-type
virus in the organs of the SCID mice and was attenuated in killing the
SCID mice. These results demonstrate the utility of using the
Tn3-based system as a mutagenesis approach for studying the
function of MCMV genes in both immunocompetent and immunodeficient animals.
 |
INTRODUCTION |
Human cytomegalovirus (HCMV) is a
ubiquitous herpesvirus which causes mild or subclinical diseases in
immunocompetent adults but may lead to severe morbidity or mortality in
neonates and immunocompromised individuals (2, 24).
Disseminated HCMV infection, common in AIDS patients and organ
transplant recipients, is usually associated with gastroenteritis,
pneumonia, and retinitis (12, 29). Studies on the functions
of viral genes in HCMV replication in vivo are essential for
understanding viral pathogenesis and developing new strategies to
combat the viral infection. However, there are currently no suitable
animal models for HCMV infection. HCMV only propagates in human cells
and grows slowly due to a long lytic replication cycle (24).
These properties of HCMV have hampered the studies of HCMV pathogenesis
and gene function.
Infection of the mouse with murine CMV (MCMV) provides a valuable in
vivo model for studying the biology of CMV infection. This is because
infection of mice by MCMV resembles in many ways its human counterpart
with respect to pathogenesis during acute infection, establishment of
latency, and reactivation after immunosuppression, transfusion, or
transplantation (2, 15, 17, 24). Its genome of 230 kb is
predicted to encode more than 170 open reading frames, 78 of which have
extensive homology to those of HCMV (5, 32). However, many
of these MCMV genes remained uncharacterized and their functions in
viral pathogenesis have not been investigated.
One of the most powerful approaches to study the function of
virus-encoded genes is to introduce mutations into the viral genome and
to screen viral mutants in both tissue culture and animals for possible
growth defects in vitro and in vivo. The construction of herpesvirus
mutants was first reported using site-directed homologous recombination
and then using transposon-mediated insertional mutagenesis (16,
25, 31, 34, 48). Methods using overlapping cosmid DNA fragments
to generate mutants of HCMV and other herpesviruses have also been
reported (7, 9, 18, 44, 45). More recently, the MCMV genome
as well as the genomes of other herpesviruses have been cloned into a
bacterial artificial chromosome (BAC), and MCMV mutants were
successfully generated from the BAC-based viral genome by both
site-directed homologous recombination and transposon-mediated
insertional mutagenesis (3, 11, 23, 37, 41-43, 47). It has
been shown that the BAC sequence in a BAC-based pseudorabies virus does
not affect viral pathogenesis in vivo in animals (41, 42).
Moreover, two different approaches to excise the BAC sequence from the
viral genome have been described (42, 47). These studies
have greatly facilitated the identification of the functions of viral
genes in tissue culture and in animals.
We have recently applied a Tn3 transposon-mediated shuttle
mutagenesis system to generate MCMV mutants (49). In this
approach, the transposon is inserted into a plasmid library of MCMV
genomic DNA in Escherichia coli. Regions bearing an
insertion mutation are then transferred to the MCMV genome by
homologous recombination. In the study reported here, we have
successfully used this approach to generate MCMV mutants containing
transpositional insertions in open reading frames m09 and M83. Our
results provide the first direct evidence to suggest that the m09 open
reading frame is not essential for viral replication in NIH 3T3 cells.
Studies in BALB/c-Byj mice and CB17 severe combined immunodeficient
(SCID) mice indicated that m09 is dispensable for viral growth in the salivary glands, lungs, livers, spleens, and kidneys of these animals
that were infected intraperitoneally with the viral mutant. Moreover,
our data suggest that the presence of the transposon sequence in the
viral genome does not significantly affect viral growth in both the
BALB/c and SCID mice. These results demonstrate the feasibility of
using this Tn3-based system to study the functions of MCMV
genes in both immunocompetent and immunodeficient hosts.
 |
MATERIALS AND METHODS |
Cells and viruses.
The wild-type Smith strain of MCMV was
obtained from the American Tissue Culture Collection (ATCC) (Rockville,
Md.). NIH 3T3 cells (ATCC CRL1658) were cultured in a humidified
incubator at 37°C and in the presence of 5% CO2. Cells
were maintained in complete medium containing Dulbecco modified Eagle
medium (DMEM) supplemented with 10% NuSerum (Becton Dickinson, Mass.).
The Smith strain and the viral mutants, Rvm09 and RvM83, were
propagated in NIH 3T3 cells as described previously (49).
Isolation of viral DNA and construction of a MCMV DNA subclone
pool.
NIH 3T3 cells were infected at a multiplicity of infection
(MOI) of 0.1 PFU per cell. Approximately 5 to 7 days postinfection, almost all of the cells showed cytopathic effects (CPE) and were harvested. Viral particles and DNA were purified as described previously (6, 22). To generate the MCMV genomic pool, the DNA was partially digested with the restriction enzyme
Sau3A. The first two nucleotides of the 3' overhang sequence
of the digested DNA fragments were then filled in with dGTP and dATP.
The digested DNA fragments were separated on 0.8% agarose gels. DNA
fragments in the size range of 1.6 to 4 kb were purified and cloned
into pHSS6-SalI (a gift from Michael Snyder of Yale
University) (4, 14, 40).
Transposon shuttle mutagenesis to generate the MCMV DNA pool that
contained the transposon sequence.
The MCMV genomic fragment pool
was first transformed into B211 {RDP146 [F
recAI(
lac-pro)rpsE; spectinomycin
resistant] with plasmid pLB101} and colonies were selected on plates
that contained kanamycin and chloramphenicol. These colonies were then
mated with strain XZ95 which contained the transposon
(Tn3-gpt) sequence (49). The Tn3-gpt
construct was derived from a E. coli Tn3
transposon and contained the gpt gene (49). The
mixture was then allowed to grow on plates that contained tetracycline,
kanamycin, and chloramphenicol for 2 days at 30°C. At this time,
cointegration occurred. Finally, the cointegrates were resolved to
generate the plasmid pHSS6::MCMV fragments containing a
Tn3 insertion by mating the bacteria with strain E. coli 70 (NG135 [K-12 recA56 gal-delS165
strA; streptomycin resistant] with plasmid pNG54). The plasmid
DNA that contained the viral DNA fragments with a randomly inserted
transposon was isolated and used to transform into E. coli
DH5
for long-term storage.
In order to identify the genes that contained the transposon insertion
and the orientation of the insertion relative to the open reading
frame, plasmid DNAs that contained the mutated MCMV fragments were
isolated. The junctions between the transposon and the viral DNA
sequences were sequenced using the Sequenase sequencing system
(Amersham, Inc., Arlington Heights, Ill.) with primer FL110PRIM
(5'-GCAGGATCCTATCCATATGAC-3').
Construction of recombinant MCMV.
The transposon-MCMV DNA
constructs were isolated and digested with NotI in order to
release the genomic fragments containing the transposon (Fig.
1B). The excised fragments (1 to 3 µg)
and full-length intact viral genomic DNA (Smith strain, 8 to 12 µg) were subsequently cotransfected into mouse NIH 3T3 fibroblasts using a
calcium phosphate precipitation protocol (Gibco BRL, Grand Island,
N.Y.). The recombinant virus was purified by six rounds of
amplification and plaque purification in the presence of 25 µg of
mycophenolic acid (Gibco BRL) and 50 µg of xanthine (Sigma, St.
Louis, Mo.) per ml, as described previously (46, 49). For
each cotransfection, several viral plaques were picked and expanded.
Virus stocks were prepared by growing the viruses in T150 flasks of NIH
3T3 cells. In order to determine the location of the transposon
insertion within the viral genome, the junctions of the transposition
in the recombinant viral DNA were directly sequenced with primer
FL110PRIM using the fmol Cycle Sequencing Kit (Promega, Inc., Madison,
Wis.).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of the structure of the
transposon construct used for mutagenesis (A) and the procedure for the
construction of MCMV mutants that contained random transposon
insertions (B). TR, terminal repeat; Tet, tetracycline resistance gene;
gpt, gene that encodes guanine phosphoribosyltransferase
(gpt); poly(A), transcription termination signal.
|
|
Southern and Northern analyses of recombinant viruses.
Viral
genomic DNA was isolated from NIH 3T3 cells as described previously
(20-22). Briefly, cells that exhibited 100% CPE were washed with phosphate-buffered saline (PBS) and then subjected to
proteolysis by a solution that contained sodium dodecyl sulfate and
proteinase K. The genomic DNA was purified by extraction with phenol-chloroform, followed by precipitation with 2-propanol
(22). Southern analyses were carried out to detect the
presence of the transposon within the viral genome. Briefly, genomic
DNA was digested with either HindIII, NotI,
or EcoRI; separated on a 0.8% agarose gel; transferred to a
Zeta-Probe nylon membrane (Bio-Rad, Hercules, Calif.); hybridized with
the 32P-radiolabeled DNA probes that contain the transposon
and the MCMV sequences; and finally analyzed with a STORM840
phosphorimager (49). The labeled DNA probes were prepared by
random primer synthesis (Boehringer Mannheim, Indianapolis, Ind.).
Cytoplasmic RNAs were isolated from MCMV-infected cells as described
previously (
21). Cells were infected with virus at
an MOI of
10 and harvested at different time points postinfection.
In the
experiments to assay the expression of immediate-early
transcripts,
cells were pretreated with 100 µg of cycloheximide
(Sigma) per ml and
then infected with viruses and harvested 6
h postinfection. Viral
RNAs were separated in a 1% agarose gel
that contained formaldehyde,
were transferred to a nitrocellulose
membrane, were hybridized with the
32P-radiolabeled DNA probes that contained the MCMV
sequences, and
were finally analyzed with a STORM840 phosphorimager.
The DNA
probes used for Northern analyses were generated by PCR using
viral DNA as the templates and radiolabeled with a random primer
synthesis kit in the presence of [

-
32P]dCTP
(Boehringer Mannheim). The 5' PCR primers used in the construction
of
DNA probes for the Northern analysis of m09, M83, and M25 transcripts
were m09/1 (5'-TTCTGGCACCGTCACACCAG-3'), M83/1
(5'-AGACGTGTACGACGAGCAGG-3'),
and M25/1
(5'-AATCCATCTCCGCATCCGAACCCTG-3'), respectively. The
3' PCR
primers used were m09/2 (5'-GGAGTTATCTTATGTGTAAT-3'), M83/2
(5'-AACGTGAAGTTGAACGGTTC-3'), and M25/2
(5'-CCTCAGACGGGATGCTCAATGGCTT-3'),
respectively.
Growth kinetics of recombinant viruses.
The analyses of the
growth of the recombinant viruses in vitro were carried out as
described previously (49). In brief, 5 × 105 NIH 3T3 cells were infected at an MOI of either 0.5 or
5.0 PFU per cell. The cells and medium were harvested at 0, 1, 2, 4, and 7 days postinfection, and viral stocks were prepared by adding an
equal volume of 10% skim milk, followed by sonication. The titers of
the viral stocks were determined by plaque assays in triplicate experiments.
Viral growth studies in animals.
Three-week-old male
BALB/c-Byj mice (Jackson Laboratory, Bar Harbor, Maine) or six-week-old
CB17 SCID mice (National Cancer Institute, Bethesda, Md.) were infected
intraperitoneally with 103 to 104 PFU of each
virus. The animals were sacrificed at different time points (e.g., 3 days) postinoculation as specified in Results. For each time point, at
least three animals were used as a group and infected with the same
virus. The whole salivary gland, about 0.1 to 0.2 g of the liver,
one-quarter of the lungs, the whole spleen, and one of the kidneys were
collected individually into 3-ml sterile tubes. To avoid
cross-contamination of viruses between organs and different
recombinants, surgical tools (forceps and scissors) were rinsed once in
PBS, rinsed three times in 70% ethanol, and flamed after each rinse in
ethanol. Each sample was suspended in a mixture of DMEM and 10% skim
milk (50% [vol/vol]) at 0.1 g/ml. The organs were then sonicated on
ice using a 550 Sonic Dismembrator (Fisher Scientific, Pittsburgh, Pa.)
until the organ became homogenized. The samples were stored at
80°C
until titers of the viruses in these samples were determined.
Titers of viruses harvested from the mice were determined on NIH 3T3
cells in six-well tissue culture plates (Corning, Inc.,
Corning, N.Y.).
Briefly, cells were first split 1:30 from T150
flasks into six-well
plates and cultured overnight (16 to 24 h)
and then infected with
the viruses at 10-fold serial dilutions.
After 2 h of incubation
with the homogenates diluted in 1 ml of
complete medium at 37°C with
5% CO
2, the cells were overlaid with
fresh complete medium
containing 1% agarose and cultured for 4
to 5 days before the plaques
were counted under an inverted microscope.
Virus titers were recorded
as the PFU/milliliter of organ homogenates.
The titer of each sample
was determined in triplicate. The limit
of virus detection in the organ
homogenates was 10 PFU/ml of the
sonicated mixture. Those samples that
were negative at a 10
1 dilution were given a titer value
of 10 (10
1) PFU/ml.
To determine the mortality of the animals infected with the Smith
strain, Rvm09, and RvM83, the CB17 SCID mice (five animals
per group)
were infected intraperitoneally with 10
4 PFU of each virus.
The mortality of the infected animals was
monitored for at least 46 days postinfection, and the survival
rates were
determined.
 |
RESULTS |
Isolation of MCMV mutants containing the transposon insertions at
open reading frames m09 and M83.
We recently constructed an
E. coli Tn3-based transposon (Fig. 1A) which
contained the expression cassette encoding guanine phosphoribosyltransferase (i.e., gpt) and, in addition, a
transcription termination site (49). The gpt gene
was used as a selectable marker in the construction of MCMV recombinant
viruses (46). The gpt expression cassette was
inserted such that its transcription termination site functioned in the
opposite direction as the other poly(A) signal presented in the
transposon (Fig. 1A). Such a design would assure that the transcription
of the targeted gene is truncated without altering the expression of
nearby genes that may share a common poly(A) signal with the disrupted
gene. To generate a pool of MCMV DNA fragments that contained a
randomly inserted transposon, virus DNA was first purified and
partially digested with Sau3A. Digested fragments in the
size range of 1.6 to 4 kb were then cloned into vector
pHSS6-SalI (4, 14, 40) to generate a MCMV genomic
library. The transposon was introduced into this MCMV DNA library
through a shuttle mutagenesis protocol, as described previously (see
Materials and Methods) (49), to generate a pool of MCMV
genomic sequences that contained the transposon sequence (Fig. 1B).
To generate a pool of MCMV mutants that contained the transposon
randomly inserted at the viral genome, the pool of MCMV genomic
fragments which contained a transpositional insertion were
cotransfected
with the full-length genomic DNA of the wild-type virus
(Smith
strain) into mouse NIH 3T3 cells to allow homologous
recombination
to occur. The cells that harbored the progeny viruses
were allowed
to grow in the presence of mycophenolic acid and xanthine,
which
selects for
gpt expression (
27,
46). The
recombinant viruses
that contained the transposon and expressed the
gpt protein were
isolated after multiple rounds of selection
and plaque purification.
Two of the recombinant viruses generated were
further characterized
and are reported here. These viruses, designated
Rvm09 and RvM83,
contained the transposon within open reading frames
m09 and M83,
respectively (Fig.
2). The
locations of the transposon sequence
in the viral genome were
determined by direct sequencing of the
genomic DNA of the recombinant
viruses. Sequence analyses of the
junction between the transposon and
the viral sequence revealed
that the locations of the transposon in
Rvm09 and RvM83 were at
nucleotide positions 8683 (m09), and 118237 (M83), respectively,
in reference to the genome sequence of the
wild-type Smith strain
(
32) (Fig.
2A, data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
(A) The locations of the transposon insertions in the
recombinant viruses. The transposon sequence is shown as a filled bar,
while the coding sequence of each open reading frame is represented by
an open arrow. The orientation of the arrow represents the direction of
the translation and transcription predicted based on the nucleotide
sequence (32). The numbers represent the sizes of the DNA
fragments of the mutant viruses that contained the transposon sequence
and were generated by digestion with HindIII (H),
NotI (N), or EcoRI (E). (B) Southern blot
analyses of the viral mutants. The DNA fractions were isolated from
cells infected with the wild-type (WT) virus and different MCMV
mutants. The DNA samples (20 µg) were digested with
HindIII (H), NotI (N), or EcoRI
(E); separated on 0.8% agarose gels; transferred to a Zeta-Probe
membrane; and hybridized to a DNA probe. The probes used for the
analyses were the plasmids that contained the MCMV DNA fragments
inserted with the transposon sequence.
|
|
In vitro characterization of MCMV mutants in tissue culture.
Southern hybridization analyses with DNA probes containing the
transposon and the viral sequence were used to examine the genomic
structure of the recombinant viruses and determine if the mutants
contained the transposon insertion (Fig. 2B). Analysis of the
HindIII-digested DNA of each recombinant virus clearly showed a small fragment of 1.8 kb representing the gpt gene
fragment, indicating the presence of the transposon sequence within the viral genome (Fig. 2B, lanes 1 and 5). This conclusion is further supported by the results of Southern analyses of the mutant DNAs digested with another restriction enzyme (i.e., EcoRI for
Rvm09 and NotI for RvM83) (lanes 3 and 4 and lanes 7 and 8).
In each case, the genomic fragment from the transposon-containing
viruses should be bigger than that of the wild-type virus by 3.6 kb,
which is the size of the transposon. The stocks of these recombinant viruses appeared to be pure and free of the wild-type strain, since the
hybridizing DNA fragments from the mutants did not comigrate with those
of the wild-type Smith strain (Fig. 2B, lanes 1 to 8). For example, the
hybridization patterns of the Rvm09 and Smith strain DNAs digested with
HindIII gave rise to three DNA bands (28.9, 6.1, and 1.8 kb) and one DNA band (33.1 kb), respectively (Fig. 2B, lanes 1 and 2).
Meanwhile, the hybridized species (13.6 kb) of the
EcoRI-digested Rvm09 DNA migrated differently from that (10 kb) of the wild-type viral DNA digested with the same enzyme (Fig. 2B,
lanes 3 and 4). The sizes of the hybridized DNA fragments (Fig. 2B)
were consistent with the predicted digestion patterns of the
recombinant viruses based on the MCMV genomic sequence (32)
and the location of the transposon insertion in the viral genome as
determined by sequence analysis (Fig. 2A). The restriction enzyme
digestion patterns of the regions of the mutant genomic DNAs other than
the transposon insertional site appeared to be identical to those of
the parental Smith strain, as indicated by ethidium bromide staining of
the digested DNAs (data not shown). This observation suggested that
regions of the viral genome other than those containing the transposon
insertion remained intact in these MCMV mutants.
It is expected that the transcription of the targeted genes would be
disrupted due to the presence of the two transcription
termination
signals within the transposon. Specifically, the regions
of the open
reading frames downstream from the transposon insertion
site will not
be transcribed due to the presence of these termination
signals. To
determine whether this is the case, cytoplasmic RNAs
were isolated from
cells infected with the mutant viruses at different
time points (e.g.,
4, 12, and 24 h) postinfection. Northern analysis
was carried out
to examine the expression of the transcripts from
the m09 and M83
regions downstream from the transposon insertion
site (Fig.
3). In the two mutant viruses, the
transposon was found
to insert in the 5'-coding region of m09 and the
central region
of M83, respectively (Fig.
2A). The probes used in the
Northern
analyses contained the DNA sequences complementary to the m09
and M83 coding region about 100 nucleotides downstream from the
site of
the transposon insertion. Substantial amounts of transcripts
from m09
and M83 open reading frames were found in RNA fractions
isolated from
cells infected with the parental Smith strain (Fig.
3, lanes 2 and 5).
The size of the single transcript from m09
was ca. 3 kb (lane 2) and is
consistent with the length of this
open reading frame (293 amino acids)
(
32). RNA transcripts of
about 5, 7 to 7.5, and 10 kb were
detected in the M83 region (lane
5) and are consistent with the
previous observations (
8). However,
these transcripts were
not detected in RNA fractions isolated
from cells infected with Rvm09
and RvM83 when the same probes
were used (Fig.
3, lanes 3 and 6). The
level of MCMV M25 transcript
(
10,
49) was used as the
internal control for the expression
of these transcripts. As an example
shown in Fig.
3 (lanes 7 to
9), the level of M25 transcript detected in
cells that were infected
with Rvm09 was found to be similar to that of
M25 transcript in
cells infected with the Smith strain (Fig.
3, lanes 8 and 9).
Similar results were also obtained when the level of the M25
transcript
was used as the internal control for the expression of the
M83
transcripts from RvM83 (data not shown). Thus, the insertions
truncated or disrupted the transcripts expressed from these open
reading frames.

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot analyses of the RNA fractions isolated
from cells that were mock infected (lanes 1, 4, and 7) or infected with
the wild-type virus (WT) (lanes 2, 5, and 8) and the mutant viruses
(lanes 3, 6, and 9). A total of 107 NIH 3T3 cells were
infected with each virus at an MOI of 10 PFU/cell, and cells were
harvested 24 h postinfection. Equal amounts of RNA samples (30 µg) were separated on agarose gels that contained formaldehyde,
transferred to a nitrocellulose membrane, and hybridized to a
32P-radiolabeled probe that contained the sequence of m09
(lanes 1 to 3), M83 (lanes 4 to 6), or M25 (lanes 7 to 9).
|
|
To determine whether the recombinant viruses had any growth defects in
vitro, NIH 3T3 cells were infected with these viruses
at both low and
high MOIs. The growth rates of these viruses in
mouse NIH 3T3 cells
were assayed and compared to those of the
parental Smith strain. These
results, obtained from triplicate
experiments, are shown in Fig.
4 and indicate that the peak titers
of
Rvm09 and RvM83 were similar to that of the parental Smith
strain. The
fact that these viruses did not exhibit significant
growth defects is
consistent with the previous observations that
M83 is dispensable for
MCMV replication in NIH 3T3 cells (
26).
Moreover, these
results, combined with those from the Southern
analyses, suggest that
m09 is not essential for viral growth in
tissue culture.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
In vitro growth of MCMV mutants in tissue culture. Mouse
NIH 3T3 cells were infected with each virus at an MOI of either 0.5 PFU
(A) or 5 PFU (B) per cell. At 0, 1, 2, 4, and 7 days postinfection,
cells and culture media were harvested and sonicated. The viral titers
were determined by plaque assays on NIH 3T3 cells. The values of the
viral titer represent the average obtained from triplicate experiments.
The standard deviation is indicated by the error bars.
|
|
Replication of the transposon-containing viral mutants in
immunocompetent animals.
In order to use the Tn3-based
transposon system to generate MCMV mutants and study the phenotypes of
the mutants in vivo, it is necessary to determine whether the presence
of the transposon sequence in the viral genome does not significantly
affect viral replication in animals. To determine accurately the
capability of the viral mutants to grow in animals, a low dose of
viruses was used for inoculation. BALB/c-Byj mice were injected
intraperitoneally with 103 PFU of Rvm09, RvM83, and Smith
strain. At 1, 3, 7, and 14 days postinfection, salivary glands, lungs,
spleens, livers, and kidneys were harvested, and the virus titers in
these five organs were determined. These organs are among the major
targets for MCMV infection (2, 15, 17, 24). At 14 days
postinfection, the titers of Rvm09 in the salivary glands were similar
to those of the Smith strain, while a reduction of 500-fold in the
virus titer was found in the salivary glands of the RvM83-infected
animals (Fig. 5). At 7 days
postinfection, the titers of Rvm09 in the lungs, spleens, livers, and
kidneys were also similar to those of the Smith strain. In contrast, a
reduction of at least 20-fold in the virus titer was found in the
lungs, spleens, livers, and kidneys of the animals infected with Rvm83
(Fig. 5). These results are consistent with previous observations that
a MCMV mutant with a deletion at M83 was attenuated in replication in
these organs (26). Since Rvm09 replicated as equally well as
the Smith strain in all the organs examined, the presence of the
transposon sequence per se within the viral genome appears to have no
significant effect on viral replication in BALB/c mice, at least in
these organs. These results further suggest that the m09 open reading frame is dispensable for viral replication in these organs of BALB/c
mice.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Titers of MCMV mutants in salivary glands (A), lungs
(B), spleens (C), livers (D), and kidneys (E) of the infected BALB/c
mice. BALB/c-Byj mice were infected intraperitoneally with
103 PFU of each virus. At 1, 3, 7, and 14 days
postinfection, the animals (three mice per group) were sacrificed. The
salivary glands, lungs, spleens, livers, and kidneys were collected and
sonicated. The viral titers in the tissue homogenates were determined
by standard plaque assays in NIH 3T3 cells. The limit of detection was
10 PFU/ml of the tissue homogenate. The viral titers represent the
average obtained from triplicate experiments. The error bars indicate
the standard deviation. Error bars that are not evident indicate that
the standard deviation was less than or equal to the height of the
symbols.
|
|
Replication of the transposon-containing viral mutants in
immunodeficient animals.
Previously studies have indicated that
immunodeficient animals are extremely susceptible to MCMV infection
(13, 28, 30, 33). For example, the CB17 SCID mice, which
lacks functional T and B lymphocytes, are sensitive to an extremely low
level of viral replication since these animals succumb to as little as 10 PFU of MCMV (28, 30). These animals have served as an
excellent model in determining the virulence of different MCMV strains
and mutants and in studying the mechanism of how they cause
opportunistic infections in immunocompromised hosts. In order to use
the Tn3-based transposon system to generate MCMV mutants and
study the phenotypes of the mutants in vivo in an immunodeficient host,
it is also necessary to determine whether the presence of the
transposon sequence in the viral genome does not significantly affect
viral replication in these animals. Two sets of experiments with the SCID mice were carried out to address this issue. First, the survival rates of the animals infected with Rvm09 and RvM83 were determined and
compared with those infected with the Smith strain. The SCID mice (five
animals per group) were injected intraperitoneally with 104
PFU of Rvm09, RvM83, and Smith strain. As shown in Fig.
6, the survival rates of the animals
infected with Rvm09 were similar to those of the animals infected with
the Smith strain. Half of the animals infected with Rvm09 and the Smith
strain died within 22 and 23 days postinfection, respectively. In
contrast, no animals infected with RvM83 were found dead until 40 days
postinfection.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 6.
Mortality of the SCID mice infected with the Smith
strain, Rvm09, and RvM83. CB17 SCID mice (five animals per group) were
infected intraperitoneally with 104 PFU of each virus.
Mortality of mice was monitored for 46 days postinfection, and survival
rates were determined.
|
|
To further study the pathogenesis of the mutant viruses in these
immunodeficient animals, the replication of the viral mutants
in
different organs of the animals was studied during a 21-day
infection
period before the mortality of the animals infected
with Smith strain
became apparent. SCID mice (three animals per
group) were injected
intraperitoneally with 10
4 PFU of Rvm09, RvM83, and Smith
strain. At 1, 3, 7, 10, 14, and
21 days postinfection, salivary glands,
lungs, spleens, livers,
and kidneys were harvested, and the viral
titers in these five
organs were determined. During the 21-day
infection period, the
titers of Rvm09 in the five organs were not
significantly different
from those of the Smith strain (Fig.
7). In contrast, at 21 days
postinfection, the titers of RvM83 found in the salivary glands,
lungs,
spleens, and livers of the infected animals were 5,000-,
500-, 100-, and 60-fold less than the titers of the Smith strain
found in the same
organs from the infected animals, respectively
(Fig.
7). No viruses
were detected in the kidneys of the animals
infected with RvM83, while
a viral titer of about 10
4 PFU/ml was found in those of the
animals infected with the Smith
strain and Rvm09. The titers of RvM83
in the organs of the infected
SCID mice at 39 days postinfection are
similar to those of the
wild-type virus in the infected animals at 21 days postinfection
(data not shown). These results suggest that RvM83
is attenuated
and its infection exhibits delayed pathogenesis in SCID
mice.
It is possible that the observed results with RvM83 are due to
a
second mutation rather than the actual transposon insertion
at M83. To
address this issue, another viral mutant with a transposon
insertion at
M83 was isolated independently from RvM83. The titers
of this second
mutant in the organs of the infected animals are
similar to those of
RvM83 (J. Xiao, X. Zhan, E. Haghjoo, and F.
Liu, unpublished results).
Thus, it is unlikely that a second
mutation is responsible for the
results with RvM83, although we
cannot completely rule out this
possibility. Because Rvm09 replicated
as well as the Smith strain in
all of the organs examined, the
presence of the transposon sequence per
se within the viral genome
appears to have no significant effect on
viral replication in
vivo in these animals, at least not in these
organs. Together,
these results suggest that the m09 open reading frame
is dispensable
for viral replication in these organs of the SCID mice.
Moreover,
these observations suggest that M83 is important for viral
replication
in immunodeficient animals.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
Titers of MCMV mutants in the salivary glands (A), lungs
(B), spleens (C), livers (D), and kidneys (E) of the infected SCID
mice. CB17 SCID mice were infected intraperitoneally with
104 PFU of each virus. At 1, 3, 7, 10, 14, and 21 days
postinfection, the animals (three mice per group) were sacrificed. The
salivary glands, lungs, spleens, livers, and kidneys were collected and
sonicated. The viral titers in the tissue homogenates were determined
by standard plaque assays in NIH 3T3 cells. The limit of detection was
10 PFU/ml of the tissue homogenate. The viral titers represent the
average obtained from triplicate experiments. The error bars indicate
the standard deviation. Error bars that are not evident indicate that
the standard deviation was less than or equal to the height of the
symbols.
|
|
Stability of the transposon mutations in the recombinant
viruses.
Our previous studies have indicated that a transposon
sequence inserted at the 3'-terminal region of the MCMV genome (i.e., the m155 open reading frame) is stable during viral replication in NIH
3T3 cells and in BALB/c mice (49). However, it is not known
whether the transposon sequence inserted at the 5'-terminal sequence of
the viral genome is also stable during viral propagation. Equally
unclear is whether the insertional mutation is stable during viral
propagation in immunodeficient animals, in which the viral replication
may achieve a higher level than that in immunocompetent mice. To
address these issues, two sets of experiments were carried out. First,
recombinant virus Rvm09 and RvM83 were used to infect NIH 3T3 cells at
an MOI of <0.01 and allowed to grow for five generations (60 days) in
the absence of gpt selection. Second, 104 PFU of
viruses were used to infect both the BALB/c and SCID mice. At 14 days
postinfection, salivary glands and lungs were harvested from the
infected animals and sonicated to release the virus. Viruses were
recovered by infecting NIH 3T3 cells with the sonicated tissue
homogenates. Viral DNAs were purified from the infected cells, and
their restriction digestion patterns were analyzed in agarose gels.
Figure 8 shows a Southern analysis of the
Rvm09 viral DNAs with a DNA probe that contained the transposon and m09
open reading frame sequence. These results indicated that no change in
the hybridization patterns of Rvm09 occurred as a result of viral
growth for five generations (60 days) in cultured cells (Fig. 8, lane
3) or in animals for 14 days (lanes 4 to 7). Moreover, the overall
HindIII-digestion patterns of Rvm09 DNA isolated from
either infected cultured cells or animals were identical to those of
the original recombinant virus, as visualized by ethidium bromide
staining of the viral DNAs (data not shown). Similar results were also
observed in experiments with RvM83 (data not shown). Thus, the
transposon insertion in Rvm09 and RvM83 appeared to be stable in tissue
culture and in both BALB/c and SCID mice.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 8.
The stability of the transposon mutations in tissue
cultured cells and in BALB/c and SCID mice. Viral DNAs were either
isolated from cells that were infected with Rvm09 (MOI = <0.01)
and allowed to grow in culture for 5 days (P0) (lane 2) or five
generations (60 days) (P5) (lane 3) or from cells that were infected
with the virus collected from the salivary glands (SG, lanes 4 and 6)
and lungs (LU, lanes 5 and 7) of either BALB/c (BALB/c, lanes 4 and 5)
or SCID mice (SCID, lanes 6 and 7) 14 days after intraperitoneal
inoculation with 104 PFU of Rvm09. Southern blot analyses
of the viral DNA fractions digested with HindIII are
shown. The DNA of the wild-type virus (WT) is shown in lane 1. The
32P-radiolabeled probe was derived from the same plasmid
which was used for Southern analyses of Rvm09 in Fig. 2 and contained
the transposon and the m09 open reading frame sequence.
|
|
 |
DISCUSSION |
Analyses of herpesviral genome by transposon-mediated insertional
mutagenesis.
Transposon-mediated mutagenesis has been widely used
to study gene function in viruses, bacteria, yeast, and mammalian
cells. Previously, Tn5 and phage-mu-based transposons have
been used in the genetic analysis of herpes simplex virus 1 (34,
48). More recently, transposons derived from Tn1721
and Tn5 have also been used in the mutagenesis of the
BAC-based genomes of MCMV and pseudorabies virus, respectively (3,
41). The system we used is based on an E. coli
Tn3 transposon which has been employed in the mutagenesis
studies of the genomes of Saccharomyces cerevisiae and other
organisms such as Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae (35, 36, 39, 40). One
of the major advantages of the Tn3 system is its
transposition immunity. A plasmid already containing a copy of
Tn3 is immune to further insertions of the transposon. This
immunity is due to the presence of a 38-nucleotide sequence, which is
also found in the E. coli chromosome (19).
Therefore, Tn3 mutagenesis is simple, is straightforward, and yields little background since most of the transposition occurs in
the target sequence (e.g., MCMV DNA) rather than in the E. coli chromosome sequence (14). In this study, the
constructed Tn3-gpt transposon efficiently transposed into
the MCMV DNA fragments, and viral mutants that contained transposon
mutations at open reading frames m09 and M83 were successfully
constructed. Moreover, preliminary characterization of 20 different
mutants among a library of ca. 500 isolates revealed that most of these
mutants contained the transposon insertion at different locations of
the genome (data not shown). These results further demonstrate that the
Tn3 system can be used for simultaneous isolation of
multiple viral mutants and may have advantages over traditional
homologous recombination system for systematic generation of viral mutants.
In order to identify the function of virus-encoded genes, we intend to
introduce mutations into the viral genome using the
Tn
3-based transposon and to screen viral mutants in both
tissue
culture and animals for possible growth defects in vitro and in
vivo. However, several criteria must be satisfied if the
Tn
3-based
transposon is to be used as a mutagenesis tool to
generate MCMV
mutants for studies of viral replication in vitro and in
vivo.
This includes the stability of the transposon within the viral
genome during viral replication in vitro and in vivo and its effect
on
viral pathogenesis in vivo. In our study, the transposon insertion
in
Rvm09 and RvM83 was stable during the replication of the viral
mutant
in vitro in NIH 3T3 cells and in vivo in both immunocompetent
and
immunodeficient animals (Fig.
8 and data not shown). The viral
genome
other than the transposon insertion region appeared to
be intact in
these MCMV mutants, as suggested by the results of
the ethidium bromide
staining of the digested viral DNAs (data
not shown). These results
strongly suggest that the transposon
insertion in the constructed MCMV
mutants is stable during viral
replication in vitro and in
vivo.
Our results also indicated that the transposon sequence does not
significantly affect viral replication in vivo in both immunocompetent
and immunodeficient animals. Viral mutant Rvm09, when used to
infect
BALB/c and SCID mice intraperitoneally, exhibited levels
of replication
in all five organs examined similar to those of
the wild-type virus
(Fig.
5 and
7). Moreover, the mortality rates
of the SCID mice infected
with this viral mutant were similar
to those of the animals infected
with the Smith strain (Fig.
6).
These results suggest that the presence
of the transposon sequence
does not significantly affect viral
virulence and pathogenesis.
Thus, the Tn
3-gpt system is
suitable for genetic analyses of the
functions of MCMV genes in
vivo.
Compared to the BAC-based viral construct technology, the
Tn
3-gpt system requires time-consuming plaque purification
of viral
mutants and cannot be used for generating mutations in viral
genes
that are essential for growth in cell culture. The BAC-based
mutagenesis
approach provides a powerful and convenient strategy to
generate
MCMV mutants, especially those that contain mutations at the
essential
genes (
3,
41). Meanwhile, the presence of the
transposon
sequence as well as the BAC sequence inserted at two
different
locations of the same viral genome may make it difficult to
analyze
the correlation between the functions of the genes disrupted by
the transposon and the phenotypes observed in animals in vivo.
Recently, it has been shown that the BAC sequence in a BAC-based
pseudorabies virus does not affect viral pathogenesis in vivo
in
animals (
41,
42). Moreover, two different approaches to
excise the BAC sequence from the viral genome have been described
(
42,
47). These studies will further facilitate the
development
of the BAC-based mutagenesis methodology for the studies of
viral
gene functions in
vivo.
Potential function of open reading frames m09 and M83 in viral
replication.
In this study, recombinant viruses that contained the
insertional mutations at open reading frames m09 and M83 were
generated. Both viruses were able to replicate in NIH 3T3 cells. These
results are consistent with the previous observation that M83 is not
essential for MCMV replication in vitro (26). Moreover, our
results provide the first direct evidence to suggest that m09 is not
essential for viral replication in NIH 3T3 cells in vitro.
While it is possible that the functional protein products might be
synthesized from the transposon-disrupted regions, several
lines of
evidence strongly suggest that this is not the case.
First, the
transposon sequence was inserted into the 5' region
and the central
region of the coding sequences of the m09 and
M83 open reading frame,
respectively (Fig.
2A). Second, the transcription
from the regions
downstream from the transposon insertion site
was not detected in cells
infected with the mutant viruses (Fig.
3). Thus, the regions of the
target open reading frames downstream
from the transposon insertion
sites were not expressed, and the
transcripts expressed from the
disrupted open reading frames were
truncated.
Open reading frame m09 belongs to MCMV m02 gene family and is believed
to encode a membrane protein (
32). However, neither
the
transcript nor the protein product coded by this open reading
frame has
been reported. Our results indicate that a transcript
of about 3,000 nucleotides is expressed from the m09 open reading
frame. The growth
rate of Rvm09 in NIH 3T3 cells was not significantly
different from
that of the Smith strain. Since the transposon
insertion is at the 5'
terminus of the open reading frame, most
of the m09 coding sequence was
not transcribed in Rvm09 and it
is likely that no functional m09
protein was expressed from the
viral mutant. Thus, our results suggest
that m09 is not essential
for viral replication in NIH 3T3 cells. Rvm09
appeared to replicate
as well as the wild-type virus in the salivary
glands, lungs,
spleens, livers, and kidneys of both BALB/c and CB17
SCID mice
that were infected intraperitoneally. These results suggest
that
m09 is not essential for viral growth in these organs in
vivo.
M83 encodes a tegument protein and has been shown to be dispensable for
viral replication in NIH 3T3 cells (
8,
26). Its
human
counterpart, open reading frame UL83, encodes pp65, one
of the most
abundant tegument proteins and is dispensable for
HCMV replication in
tissue culture in vitro (
1,
38). The
function of UL83 in
HCMV replication in vivo remains unknown.
An MCMV mutant with a
deletion in the M83 open reading frame was
found to be attenuated in
replication in the salivary glands,
lungs, spleens, and livers of
BALB/c mice that were infected intraperitoneally
(
26).
However, whether the viral mutant is also attenuated in
immunodeficient
host such as the CB17 SCID mice has not been reported.
Our results
indicated that Rvm83 is attenuated in replication
in the salivary
glands, lungs, spleens, livers, and kidneys of
BALB/c mice. Moreover,
Rvm83 is attenuated in replicating in these
five organs of the CB17
SCID mice and in killing of these immunodeficient
animals. Similar
results were also observed with another viral
mutant that was isolated
independently from RvM83 and also contained
a transposon insertion at
M83 (data not shown). Thus, it is unlikely
that a second mutation
rather than the mutation at M83 is responsible
for the observed results
with RvM83, although we cannot completely
rule out this possibility.
Since the transposon sequence per se
in the viral genome does not
significantly affect viral replication
in these organs of SCID mice (as
in the case of Rvm09-infected
animals), our results with RvM83 suggest
that M83 is important
for viral growth in the immunodeficient animals.
It is possible
that M83, an abundant tegument protein, may be important
for optimal
growth of the virus in vivo by affecting the virion
assembly and
regulation of gene expression in animals. Meanwhile, these
results
further demonstrate the feasibility of using the
Tn
3-based mutagenesis
approach to study the function of a
viral gene by generating viral
mutants bearing a transposon insertion
at the target gene and
studying their replication in vitro and in
vivo.
Since the transposon introduces an insertional rather than a deletional
mutation, extensive studies are needed to demonstrate
that the targeted
gene is inactivated after the transposon insertion
in order to
determine the essentiality of the disrupted gene.
In vitro isolation of
multiple viral mutants that contain the
transposon inserted at the same
gene but in different locations
should further support the notion that
the disrupted gene is not
essential for viral replication in tissue
culture. Meanwhile,
to confirm the assignment of functionality of a
particular gene,
it is probably necessary to restore the insertional
mutation back
to the wild-type sequence and determine whether the
phenotype
of the rescuant viruses is similar to that of the wild-type
virus.
However, the rescue procedures may also introduce adventitious
mutations that occur elsewhere in the genome. Alternatively, another
viral mutant that contains a transposon insertion at the same
gene but
in a different location from the first mutant can be
generated using
the Tn
3 system. Examination of the phenotype of
this second
isolate should confirm the results obtained from the
first mutant.
Further exploitation of the Tn
3 system to analyze
the
functions of other MCMV genes in animals should lead to the
identification of viral determinants important for viral replication
and pathogenesis in
vivo.
 |
ACKNOWLEDGMENTS |
We thank Edward Mocarski of Stanford University for helpful
discussions and comments on the manuscript and Michael Snyder of Yale
University for providing the Tn3 transposon constructs and
the E. coli strains for transposon shuttle mutagenesis. We also thank Gerry Abenes for sharing unpublished results and Ilse Von
Reis and Chonticha Kittinunvorakoon for their technical assistance.
F.L. is a Pew Scholar in Biomedical Sciences and a recipient of a
Hellman Family Faculty Award, a Basil O'Connor Starter Scholar Research Award (March of Dimes National Birth Defects Foundation), and
a Regents Junior Faculty Fellowship (University of California). This
research has been supported by a grant from the Universitywide AIDS
research program (R98-146B).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Program in
Infectious Diseases and Immunity, School of Public Health, 140 Warren
Hall, University of California, Berkeley, CA 94720. Phone: (510)
643-2436. Fax: (510) 642-6350. E-mail:
liu_fy{at}uclink4.berkeley.edu.
 |
REFERENCES |
| 1.
|
Baldick, C. J., Jr., and T. Shenk.
1996.
Proteins associated with purified human cytomegalovirus particles.
J. Virol.
70:6097-6105[Abstract].
|
| 2.
|
Britt, W. J., and C. A. Alford.
1996.
Cytomegalovirus, p. 2493-2523.
In
B. N. Fields, et al. (ed.), Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 3.
|
Brune, W.,
C. Menard,
U. Hobom,
S. Odenbreit,
M. Messerle, and U. H. Koszinowski.
1999.
Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis.
Nat. Biotechnol.
17:360-364[CrossRef][Medline].
|
| 4.
|
Burns, N.,
B. Grimwade,
P. B. Ross-Macdonald,
E. Y. Choi,
K. Finberg,
G. S. Roeder, and M. Snyder.
1994.
Large-scale analysis of gene expression, protein localization, and gene disruption in Saccharomyces cerevisiae.
Genes Dev.
8:1087-1105[Abstract/Free Full Text].
|
| 5.
|
Chee, M. S.,
A. T. Bankier,
S. Beck,
R. Bohni,
C. M. Brown,
R. Cerny,
T. Horsnell,
C. A. Hutchison,
T. Kouzarides, and J. A. Martignetti.
1990.
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Curr. Top. Microbiol. Immunol.
154:125-169[Medline].
|
| 6.
|
Chen, D. H.,
J. Hong,
M. Lee,
F. Liu, and Z. H. Zhou.
1999.
Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus.
Virology
260:10-16[CrossRef][Medline].
|
| 7.
|
Cohen, J. I., and K. E. Seidel.
1993.
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.
Proc. Natl. Acad. Sci. USA
90:7376-7380[Abstract/Free Full Text].
|
| 8.
|
Cranmer, L. D.,
C. L. Clark,
C. S. Morello,
H. E. Farrell,
W. D. Rawlinson, and D. H. Spector.
1996.
Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.
J. Virol.
70:7929-7939[Abstract].
|
| 9.
|
Cunningham, C., and A. J. Davison.
1993.
A cosmid-based system for constructing mutants of herpes simplex virus type 1.
Virology
197:116-124[CrossRef][Medline].
|
| 10.
|
Dallas, P. B.,
P. A. Lyons,
J. B. Hudson,
A. A. Scalzo, and G. R. Shellam.
1994.
Identification and characterization of a murine cytomegalovirus gene with homology to the UL25 open reading frame of human cytomegalovirus.
Virology
200:643-650[CrossRef][Medline].
|
| 11.
|
Delecluse, H. J.,
T. Hilsendegen,
D. Pich,
R. Zeidler, and W. Hammerschmidt.
1998.
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.
Proc. Natl. Acad. Sci. USA
95:8245-8250[Abstract/Free Full Text].
|
| 12.
|
Gallant, J. E.,
R. D. Moore,
D. D. Richman,
J. Keruly, and R. E. Chaisson.
1992.
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine.
J. Infect. Dis.
166:1223-1227[Medline].
|
| 13.
|
Grundy, J. E., and C. J. Melief.
1982.
Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus.
J. Gen. Virol.
61:133-136[Abstract/Free Full Text].
|
| 14.
|
Hoekstra, M. F.,
H. S. Seifert,
J. Nickoloff, and F. Heffron.
1991.
Shuttle mutagenesis: bacterial transposons for genetic manipulations in yeast.
Methods Enzymol.
194:329-342[Medline].
|
| 15.
|
Hudson, J. B.
1979.
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.
Arch. Virol.
62:1-29[CrossRef][Medline].
|
| 16.
|
Jenkins, F. J.,
M. J. Casadaban, and B. Roizman.
1985.
Application of the mini-Mu-phage for target-sequence-specific insertional mutagenesis of the herpes simplex virus genome.
Proc. Natl. Acad. Sci. USA
82:4773-4777[Abstract/Free Full Text].
|
| 17.
|
Jordan, M. C.
1983.
Latent infection and the elusive cytomegalovirus.
Rev. Infect. Dis.
5:205-215[Medline].
|
| 18.
|
Kemble, G.,
G. Duke,
R. Winter, and R. Spaete.
1996.
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.
J. Virol.
70:2044-2048[Abstract].
|
| 19.
|
Lee, C. H.,
A. Bhagwat, and F. Heffron.
1983.
Identification of a transposon Tn3 sequence required for transposition immunity.
Proc. Natl. Acad. Sci. USA
80:6765-6769[Abstract/Free Full Text].
|
| 20.
|
Liu, F., and B. Roizman.
1993.
Characterization of the protease and other products of amino-terminus-proximal cleavage of the herpes simplex virus 1 UL26 protein.
J. Virol.
67:1300-1309[Abstract/Free Full Text].
|
| 21.
|
Liu, F., and B. Roizman.
1991.
The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.
J. Virol.
65:5149-5156[Abstract/Free Full Text].
|
| 22.
|
Manning, W. C.,
C. A. Stoddart,
L. A. Lagenaur,
G. B. Abenes, and E. S. Mocarski.
1992.
Cytomegalovirus determinant of replication in salivary glands.
J. Virol.
66:3794-3802[Abstract/Free Full Text].
|
| 23.
|
Messerle, M.,
I. Crnkovic,
W. Hammerschmidt,
H. Ziegler, and U. H. Koszinowski.
1997.
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.
Proc. Natl. Acad. Sci. USA
94:14759-14763[Abstract/Free Full Text].
|
| 24.
|
Mocarski, E. S.
1996.
Cytomegaloviruses and their replication, p. 2447-2492.
In
B. N. Fields, et al. (ed.), Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 25.
|
Mocarski, E. S.,
L. E. Post, and B. Roizman.
1980.
Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions.
Cell
22:243-255[CrossRef][Medline].
|
| 26.
|
Morrello, C. S.,
L. D. Cranmer, and D. H. Spector.
1999.
In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83).
J. Virol.
73:7678-7693[Abstract/Free Full Text].
|
| 27.
|
Mulligan, R. C., and P. Berg.
1981.
Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.
Proc. Natl. Acad. Sci. USA
78:2072-2076[Abstract/Free Full Text].
|
| 28.
|
Okada, M., and Y. Minamishima.
1987.
The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.
Microbiol. Immunol.
31:45-57[Medline].
|
| 29.
|
Palella, F. J., Jr.,
K. M. Delaney,
A. C. Moorman,
M. O. Loveless,
J. Fuhrer,
G. A. Satten,
D. J. Aschman, and S. D. Holmberg.
1998.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
N. Engl. J. Med.
338:853-860[Abstract/Free Full Text].
|
| 30.
|
Pollock, J. L., and H. W. T. Virgin.
1995.
Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
J. Virol.
69:1762-1768[Abstract].
|
| 31.
|
Post, L. E., and B. Roizman.
1981.
A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.
Cell
25:227-232[CrossRef][Medline].
|
| 32.
|
Rawlinson, W. D.,
H. E. Farrell, and B. G. Barrell.
1996.
Analysis of the complete DNA sequence of murine cytomegalovirus.
J. Virol.
70:8833-8849[Abstract].
|
| 33.
|
Reynolds, R. P.,
R. J. Rahija,
D. I. Schenkman, and C. B. Richter.
1993.
Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.
Lab. Anim. Sci.
43:291-295[Medline].
|
| 34.
|
Roizman, B., and F. J. Jenkins.
1985.
Genetic engineering of novel genomes of large DNA viruses.
Science
229:1208-1214[Abstract/Free Full Text].
|
| 35.
|
Ross-Macdonald, P.,
P. S. Coelho,
T. Roemer,
S. Agarwal,
A. Kumar,
R. Jansen,
K. H. Cheung,
A. Sheehan,
D. Symoniatis,
L. Umansky,
M. Heidtman,
F. K. Nelson,
H. Iwasaki,
K. Hager,
M. Gerstein,
P. Miller,
G. S. Roeder, and M. Snyder.
1999.
Large-scale analysis of the yeast genome by transposon tagging and gene disruption.
Nature
402:413-418[CrossRef][Medline].
|
| 36.
|
Ross-Macdonald, P.,
A. Sheehan,
G. S. Roeder, and M. Snyder.
1997.
A multipurpose transposon system for analyzing protein production, localization, and function in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
94:190-195[Abstract/Free Full Text].
|
| 37.
|
Saeki, Y.,
T. Ichikawa,
A. Saeki,
E. A. Chiocca,
K. Tobler,
M. Ackermann,
X. O. Breakefield, and C. Fraefel.
1998.
Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
Hum. Gene Ther.
9:2787-2794[Medline].
|
| 38.
|
Schmolke, S.,
H. F. Kern,
P. Drescher,
G. Jahn, and B. Plachter.
1995.
The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture.
J. Virol.
69:5959-5968[Abstract].
|
| 39.
|
Seifert, H. S.,
R. S. Ajioka,
D. Paruchuri,
F. Heffron, and M. So.
1990.
Shuttle mutagenesis of Neisseria gonorrhoeae: pilin null mutations lower DNA transformation competence.
J. Bacteriol.
172:40-46[Abstract/Free Full Text].
|
| 40.
|
Seifert, H. S.,
E. Y. Chen,
M. So, and F. Heffron.
1986.
Shuttle mutagenesis: a method of transposon mutagenesis for Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
83:735-739[Abstract/Free Full Text].
|
| 41.
|
Smith, G. A., and L. W. Enquist.
1999.
Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus.
J. Virol.
73:6405-6414[Abstract/Free Full Text].
|
| 42.
|
Smith, G. A., and L. W. Enquist.
2000.
A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.
Proc. Natl. Acad. Sci. USA
97:4873-4878[Abstract/Free Full Text].
|
| 43.
|
Stavropoulos, T. A., and C. A. Strathdee.
1998.
An enhanced packaging system for helper-dependent herpes simplex virus vectors.
J. Virol.
72:7137-7143[Abstract/Free Full Text].
|
| 44.
|
Tomkinson, B.,
E. Robertson,
R. Yalamanchili,
R. Longnecker, and E. Kieff.
1993.
Epstein-Barr virus recombinants from overlapping cosmid fragments.
J. Virol.
67:7298-7306[Abstract/Free Full Text].
|
| 45.
|
van Zijl, M.,
W. Quint,
J. Briaire,
T. de Rover,
A. Gielkens, and A. Berns.
1988.
Regeneration of herpesviruses from molecularly cloned subgenomic fragments.
J. Virol.
62:2191-2195[Abstract/Free Full Text].
|
| 46.
|
Vieira, J.,
H. E. Farrell,
W. D. Rawlinson, and E. S. Mocarski.
1994.
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.
J. Virol.
68:4837-4846[Abstract/Free Full Text].
|
| 47.
|
Wagner, M.,
S. Jonjic,
U. H. Koszinowski, and M. Messerle.
1999.
Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.
J. Virol.
73:7056-7060[Abstract/Free Full Text].
|
| 48.
|
Weber, P. C.,
M. Levine, and J. C. Glorioso.
1987.
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.
Science
236:576-579[Abstract/Free Full Text].
|
| 49.
|
Zhan, X.,
G. Abenes,
M. Lee,
I. VonReis,
C. Kittinunvorakoon,
P. Ross-Macdonald,
M. Snyder, and F. Liu.
2000.
Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.
Virology
266:264-274[CrossRef][Medline].
|
Journal of Virology, August 2000, p. 7411-7421, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kamil, J. P., Coen, D. M.
(2007). Human Cytomegalovirus Protein Kinase UL97 Forms a Complex with the Tegument Phosphoprotein pp65. J. Virol.
81: 10659-10668
[Abstract]
[Full Text]
-
Redwood, A. J., Messerle, M., Harvey, N. L., Hardy, C. M., Koszinowski, U. H., Lawson, M. A., Shellam, G. R.
(2005). Use of a Murine Cytomegalovirus K181-Derived Bacterial Artificial Chromosome as a Vaccine Vector for Immunocontraception. J. Virol.
79: 2998-3008
[Abstract]
[Full Text]
-
McGregor, A., Liu, F., Schleiss, M. R.
(2004). Molecular, Biological, and In Vivo Characterization of the Guinea Pig Cytomegalovirus (CMV) Homologs of the Human CMV Matrix Proteins pp71 (UL82) and pp65 (UL83). J. Virol.
78: 9872-9889
[Abstract]
[Full Text]
-
Abenes, G., Chan, K., Lee, M., Haghjoo, E., Zhu, J., Zhou, T., Zhan, X., Liu, F.
(2004). Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame m155 Is Deficient in Growth and Virulence in Mice. J. Virol.
78: 6891-6899
[Abstract]
[Full Text]
-
Tam, A., Zhu, J., Hai, R., Haghjoo, E., Tong, T., Zhan, X., Lu, S., Liu, F.
(2003). Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M35 Is Defective in Growth In Vivo. J. Virol.
77: 7746-7755
[Abstract]
[Full Text]
-
Zhu, J., Chen, J., Hai, R., Tong, T., Xiao, J., Zhan, X., Lu, S., Liu, F.
(2003). In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Mutation at Open Reading Frame m166. J. Virol.
77: 2882-2891
[Abstract]
[Full Text]
-
Oliveira, S. A., Park, S.-H., Lee, P., Bendelac, A., Shenk, T. E.
(2002). Murine Cytomegalovirus m02 Gene Family Protects against Natural Killer Cell-Mediated Immune Surveillance. J. Virol.
76: 885-894
[Abstract]
[Full Text]
-
Abenes, G., Lee, M., Haghjoo, E., Tong, T., Zhan, X., Liu, F.
(2001). Murine Cytomegalovirus Open Reading Frame M27 Plays an Important Role in Growth and Virulence in Mice. J. Virol.
75: 1697-1707
[Abstract]
[Full Text]
-
Lee, M., Xiao, J., Haghjoo, E., Zhan, X., Abenes, G., Tuong, T., Dunn, W., Liu, F.
(2000). Murine Cytomegalovirus Containing a Mutation at Open Reading Frame M37 Is Severely Attenuated in Growth and Virulence In Vivo. J. Virol.
74: 11099-11107
[Abstract]
[Full Text]
-
Xiao, J., Tong, T., Zhan, X., Haghjoo, E., Liu, F.
(2000). In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M43. J. Virol.
74: 9488-9497
[Abstract]
[Full Text]